Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
By combining the beneficial effects of GLP-1 and GIP signaling with glucagon-mediated thermogenesis, retatrutide delivers robust improvements in body weight regulation, glycemic control, and overall metabolic health
Beyond CagriSema, Novo Nordisk is advancing amycretin-based therapies , targeting dual gut hormones to amplify weight loss effects
Government hospitals: Where GLP-1s are available via tenders, they may be dispensed free or at heavily subsidised rates to selected high-risk patients, though this is still limited and uneven across states.[9] 4.3 Government Schemes and Insurance Ayushman Bharat (AB-PMJAY): As per recent parliamentary responses, there is currently no wide-scale inclusion of GLP-1 receptor agonists under AB-PMJAY packages.[5] State schemes: A few better-resourced state programmes and teaching institutions may provide GLP-1s to high-risk diabetes patients through special budgets or pilot projects, but this is not yet mainstream.[9] Private insurance: Most retail health insurance still focuses on hospitalisation, not long-term outpatient medicines
Full weight loss results are seen at about 1 year, when combined with diet and exercise
They may be able to prescribe a covered GLP1 for a different indication, such as diabetes or cardiovascular disease, if you qualify
